Chicago Capital, LLC Procept Bio Robotics Corp Transaction History
Chicago Capital, LLC
- $4.02 Billion
- Q3 2025
A detailed history of Chicago Capital, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Chicago Capital, LLC holds 1,568,845 shares of PRCT stock, worth $53.9 Million. This represents 1.39% of its overall portfolio holdings.
Number of Shares
1,568,845
Previous 568,972
175.73%
Holding current value
$53.9 Million
Previous $32.8 Million
70.85%
% of portfolio
1.39%
Previous 0.82%
Shares
6 transactions
Others Institutions Holding PRCT
# of Institutions
289Shares Held
45.3MCall Options Held
236KPut Options Held
91.9K-
Vanguard Group Inc Valley Forge, PA5.25MShares$180 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$120 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.16MShares$74.2 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.53MShares$52.5 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.32MShares$45.5 Million0.01% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $1.53B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...